通过通过smad2/p-smad2通路促进EndMT,GDF15影响静脉血栓形成
Yeping Li1, Huiqi Zhu1, Wanghao Xin1
1Department of Respiratory Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 Qingchun East Road, Hangzhou, Zhejiang, 310016, China.
Thrombosis journal
|September 18, 2023
概括
增长分化因子15 (GDF15) 通过Smad2/Snail通路促进内皮细胞转移到介质细胞 (EndMT) 和静脉血栓栓塞 (VTE). 抑制GDF15可以降低EndMT,改善血管功能,减少血栓形成.
科学领域:
- 心血管生物学 心血管生物学
- 疾病的分子机制.
- 血栓形成研究研究
背景情况:
- 内皮转介质转换 (EndMT) 是心血管病理学中的一个关键过程.
- 在静脉血栓栓塞 (VTE) 患者中观察到高增长分化因子15 (GDF15),但其作用尚不清楚.
研究的目的:
- 调查GDF15,EndMT和VTE之间的机制联系.
- 为了确定GDF15是否影响内皮细胞功能和血栓形成.
主要方法:
- 血清GDF15水平的回顾性临床分析.
- 建立一个小鼠深静脉血栓塞 (DVT) 模型.
- 在体外研究中,使用人静脉内皮细胞 (HUVEC) 用细胞因子刺激.
主要成果:
- 在VTE患者和DVT小鼠模型中,血清GDF15水平升高.
- 通过Smad2/p-Smad2/Snail通路,GDF15促进了HUVEC中的EndMT,并通过Smad2/p-Smad2/Snail通路损害了它们的抗凝和抗纤维解功能.
- 抑制GDF15显著减少了小鼠的静脉血栓形成.
结论:
- GDF15通过Smad2/p-Smad2/Snail路径驱动EndMT和VTE. 通过Smad2/p-Smad2/Snail路径驱动EndMT和VTE. 通过Smad2/p-Smad2/Snail路径驱动EndMT和VTE.
- 向GDF15可以逆转EndMT,恢复内皮功能,并减轻静脉血栓形成.
相关概念视频
01:30Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
01:16TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:17Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K